Table 1.
Population characteristics at MESA Exam 5
| Characteristicsa | Overall (N = 1208) | By site | |
|---|---|---|---|
| Study 1 (JHU + CO) (N = 709) | Study 2 (UMN + WFU) (N = 499) | ||
| Demographic | |||
| Age (years) | 70 ± 9 | 70 ± 9 | 69 ± 9 |
| Sex (% female) | 51.4 | 55.0 | 46.3 |
| Race/ethnicity | |||
| African American (%) | 21.5 | 36.1 | 0.8 |
| Hispanic (%) | 32.6 | 29.3 | 37.3 |
| Caucasian (%) | 45.9 | 34.6 | 61.9 |
| Cigarette smoking | |||
| Former (%) | 51.7 | 49.1 | 55.5 |
| Current (%) | 9.1 | 8.1 | 10.5 |
| Clinical and laboratory | |||
| BMI, (kg m−2) | 30 ± 6 | 30 ± 6 | 30 ± 5 |
| LDL-C (mg dl−1) | 105 ± 32 | 107 ± 33 | 102 ± 30 |
| HDL-C (mg dl−1) | 54 ± 16 | 57 ± 17 | 50 ± 13 |
| Impaired glucose tolerance (%) | 45.6 | 44.3 | 47.5 |
| Diabetes (%) | 23.0 | 25.2 | 19.8 |
| Hypertension (%) | 60.9 | 63.8 | 56.6 |
| Carotid plaque score, median (IQR) | 2 (0–4) | 2 (0–3) | 2 (0–4) |
| Coronary artery calcium score, median (IQR) | 46 (0–305) | 32 (0–227) | 76 (0–397) |
| Prevalent CVD (%) | 5.3 | 4.2 | 6.8 |
| Statin use (%) | 38.5 | 35.7 | 42.5 |
BMI body mass index, CO Columbia University, CVD cardiovascular disease, HDL-C high-density lipoprotein-cholesterol, IQR interquartile range, JHU John Hopkins University, LDL-C low-density lipoprotein-cholesterol, UMN University of Minnesota, WFU Wake Forest University
aPlus-minus values are means ± SD